Pharmaceutical Therapies for the Treatment of Obesity: A Network Meta-analysis.

[1]  G. Guyatt,et al.  Pharmacotherapy for adults with overweight and obesity: a systematic review and network meta-analysis of randomised controlled trials , 2021, The Lancet.

[2]  J. Poorolajal,et al.  Diet Therapeutics Interventions for Obesity: A Systematic Review and Network Meta-Analysis , 2021, Journal of research in health sciences.

[3]  B. Moeini,et al.  Effect of interventions based on regular physical activity on weight management in adolescents: a systematic review and a meta-analysis , 2021, Systematic Reviews.

[4]  D. Skovgaard,et al.  The effect of semaglutide 2.4 mg once weekly on energy intake, appetite, control of eating, and gastric emptying in adults with obesity , 2020, Diabetes, obesity & metabolism.

[5]  T. Wadden,et al.  Effects of Liraglutide and Behavioral Weight Loss on Food Cravings, Eating Behaviors, and Eating Disorder Psychopathology , 2019, Obesity.

[6]  Won-Young Lee,et al.  Obesity Fact Sheet in Korea, 2018: Data Focusing on Waist Circumference and Obesity-Related Comorbidities , 2019, Journal of obesity & metabolic syndrome.

[7]  M. Blüher.  Obesity: global epidemiology and pathogenesis , 2019, Nature Reviews Endocrinology.

[8]  R. Batterham,et al.  Pharmacologic therapy to induce weight loss in women who have obesity/overweight with polycystic ovary syndrome: a systematic review and network meta‐analysis , 2018, Obesity reviews : an official journal of the International Association for the Study of Obesity.

[9]  D. Patel,et al.  Pediatric obesity: Current concepts. , 2018, Disease-a-month : DM.

[10]  S. Nedjat,et al.  Quality of Life in Elderly Iranian Population Using Leiden-Padua Questionnaire: A Systematic Review and Meta-Analysis , 2017, International journal of preventive medicine.

[11]  M. Camilleri,et al.  Association of Pharmacological Treatments for Obesity With Weight Loss and Adverse Events: A Systematic Review and Meta-analysis. , 2016, JAMA.

[12]  M. Jensen,et al.  Normal-Weight Central Obesity: Implications for Total and Cardiovascular Mortality , 2015, Annals of Internal Medicine.

[13]  Gerta Rücker,et al.  Ranking treatments in frequentist network meta-analysis works without resampling methods , 2015, BMC Medical Research Methodology.

[14]  Kristian Thorlund,et al.  The PRISMA Extension Statement for Reporting of Systematic Reviews Incorporating Network Meta-analyses of Health Care Interventions: Checklist and Explanations , 2015, Annals of Internal Medicine.

[15]  E. Ladenheim.  Liraglutide and obesity: a review of the data so far , 2015, Drug design, development and therapy.

[16]  C. Apovian,et al.  Pharmacological management of obesity: an endocrine Society clinical practice guideline. , 2015, The Journal of clinical endocrinology and metabolism.

[17]  Jiming Liu,et al.  Estimating the sample mean and standard deviation from the sample size, median, range and/or interquartile range , 2014, BMC Medical Research Methodology.

[18]  Panagiota Spyridonos,et al.  Graphical Tools for Network Meta-Analysis in STATA , 2013, PloS one.

[19]  L. Wood,et al.  Diet‐induced weight loss in obese children with asthma: a randomized controlled trial , 2013, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.

[20]  Philippe Ravaud,et al.  Adjustment for reporting bias in network meta-analysis of antidepressant trials , 2012, BMC Medical Research Methodology.

[21]  Kristian Thorlund,et al.  Estimating the Power of Indirect Comparisons: A Simulation Study , 2011, PloS one.

[22]  L. Aronne,et al.  Enhanced Weight Loss Following Coadministration of Pramlintide With Sibutramine or Phentermine in a Multicenter Trial , 2010, Obesity.

[23]  S. Panigrahi,et al.  Obesity: pathophysiology and clinical management. , 2009, Current medicinal chemistry.

[24]  W. James,et al.  WHO recognition of the global obesity epidemic , 2008, International Journal of Obesity.

[25]  G. Bray,et al.  Obesity as a Disease: A White Paper on Evidence and Arguments Commissioned by the Council of The Obesity Society , 2008, Obesity.

[26]  F. Greenway,et al.  Sibutramine Plus Meal Replacement Therapy for Body Weight Loss and Maintenance in Obese Patients , 2007, Obesity.

[27]  T. Wadden,et al.  Randomized trial of lifestyle modification and pharmacotherapy for obesity. , 2005, The New England journal of medicine.

[28]  P. Crane,et al.  The efficacy and safety of sibutramine for weight loss: a systematic review. , 2004, Archives of internal medicine.

[29]  D. Dey,et al.  Effects of a natural extract of (–)‐hydroxycitric acid (HCA‐SX) and a combination of HCA‐SX plus niacin‐bound chromium and Gymnema sylvestre extract on weight loss , 2004, Diabetes, obesity & metabolism.

[30]  J. Foreyt,et al.  Sibutramine and the management of obesity , 2004, Expert opinion on pharmacotherapy.

[31]  PJ Wellman,et al.  Synergistic interactions between Fenfluramine and Phentermine , 1999, International Journal of Obesity.